Xerostomia Therapeutics companies

Key Xerostomia Therapeutics Market Players:

The presence of both established and emerging players in the industry is fostering a standard landscape for the market to escalate. Global leaders such as GSK, Colgate-Palmolive, and Johnson & Johnson are leading the market with their brand recognition and extensive distribution. Besides, emerging nations such as India and Malaysia are witnessing growth owing to the presence of generic manufacturers such as Sun Pharma and Cipla. Further, firms are focused on research in saliva substitutes and investments in terms of biotech solutions to capture niche markets.

Here is a list of key players operating in the global market:

Company Name	Country of Origin	Market Share
GlaxoSmithKline plc	UK	13.8%
Colgate-Palmolive Company	U.S.	11.2%
Johnson & Johnson	U.S.	10.5%
Sun Pharmaceutical Industries	India	9.3%
Eisai Co., Ltd.	Japan	8.2%
Novartis AG	Switzerland	xx%
Pfizer Inc.	U.S.	xx%
Bayer AG	Germany	xx%
Procter & Gamble	U.S.	xx%
Takeda Pharmaceutical	Japan	xx%
Sanofi S.A.	France	xx%
AstraZeneca plc	UK	xx%
Merck & Co., Inc.	U.S.	xx%
Hikma Pharmaceuticals PLC	UK	xx%
CSL Limited	Australia	xx%
LG Chem Ltd.	South Korea	xx%
Cipla Ltd.	India	xx%
Dabur India Ltd.	India	xx%
Duopharma Biotech Berhad	Malaysia	xx%
Aspen Pharmacare Holdings	South Africa	xx%

Below are the areas covered for each company under the top 15 global manufacturers:

• Company Overview 
• Business Strategy 
• Key Product Offerings 
• Financial Performance 
• Key Performance Indicators 
• Risk Analysis 
• Recent Development 
• Regional Presence 
• SWOT Analysis